Our total synthesis efforts commenced with the known
diol 518 (Scheme 2), which was prepared from 3 in two steps
Scheme 2. Reductive Removal of the C4-OH Group
Figure 1
.
Lepadin family.
Scheme 1. General Approach to Lepadins
consisting of aza-[3 + 3] annulation and OsO4 dihydroxy-
lation19,20 of C3,4 olefin of the initial annulation product 2.21
We focused on identifying a useful reductive protocol to
(14) For recent studies in this area, see: (a) Hayashi, Y.; Gotoh, H.;
Masui, R.; Ishikawa, H. Angew. Chem., Int. Ed. 2008, 47, 4012. (b) Trost,
B. M.; Dong, G. Org. Lett. 2007, 9, 2357. (c) Schmidt, A.; Gu¨tlein, J.-P.;
Mkrrchyan, S.; Go¨rls, H.; Langer, P. Synlett 2007, 1305. (d) Pattenden,
L. C.; Wybrow, R. A. J.; Smith, S. A.; Harrity, J. P. A. Org. Lett. 2006, 8,
3089. (e) Shintani, R.; Hayashi, T. J. Am. Chem. Soc. 2006, 128, 6330. (f)
Halliday, J. I.; Chebib, M.; Turner, P.; McLeod, M. D. Org. Lett. 2006, 8,
3399. (g) Katsuyama, I.; Funabiki, K.; Matsui, M.; Muramatsu, H.; Shibata,
K. Heterocycles 2006, 68, 2087. (h) Bose, D. S.; Kumar, R. K. Heterocycles
2006, 68, 549. (i) Goodenough, K. M.; Raubo, P.; Harrity, J. P. A. Org.
Lett. 2005, 7, 2993. (j) Goodenough, K. M.; Moran, W. J.; Raubo, P.;
Harrity, J. P. A. J. Org. Chem. 2005, 70, 207. (k) Agami, C.; Dechoux, L.;
Hebbe, S.; Me´nard, C. Tetrahedron 2004, 60, 5433. (l) Ji, S.-J.; Jiang, Z.-
Q.; Lu, J.; Loh, T.-P. Synlett 2004, 831. (m) Hedley, S. J.; Moran, W. J.;
Price, D. A.; Harrity, J. P. A. J. Org. Chem. 2003, 68, 4286.
(15) For our work on developing the aza-[3 + 3] annulation method,
see: (a) Ghosh, S. K.; Buchanan, G. S.; Long, Q. A.; Wei, Y.; Al-Rashid,
Z. F.; Sklenicka, H. M.; Hsung, R. P. Tetrahedron 2008, 63, 883. (b)
Sydorenko, N.; Hsung, R. P.; Vera, E. L. Org. Lett. 2006, 8, 2611. (c)
Gerasyuto, A. I.; Hsung, R. P.; Sydorenko, N.; Slafer, B. W. J. Org. Chem.
2005, 70, 4248. (d) Sydorenko, N.; Hsung, R. P.; Darwish, O. S.; Hahn,
J. M.; Liu, J. J. Org. Chem. 2004, 69, 6732. (e) Sklenicka, H. M.; Hsung,
R. P.; Wei, L.-L.; McLaughlin, M. J.; Gerasyuto, A. I.; Degen, S. J.; Mulder,
J. A. Org. Lett. 2000, 2, 1161. (f) Hsung, R. P.; Wei, L.-L.; Sklenicka,
H. M.; Douglas, C. J.; McLaughlin, M. J.; Mulder, J. A.; Yao, L. J. Org.
Lett. 1999, 1, 509.
We12 had envisioned that all three subfamilies could be
accessed from the orthogonal protected common intermediate
1, which could be prepared from a stereoselective intermo-
lecular aza-[3 + 3] annulation13-15 using chiral vinylogous
amide 3. Given our recent success in the alkaloid synthesis
employing this annulation,16 we elected to first pursue the
most challenging member of the family, lepadin F,17
containing the 1,3-anti relative configuration for C2,8a.
Despite numerous efforts in the synthesis of lepadins, an
elegant total synthesis of lepadin F was only accomplished
very recently by Blechert.10 We report here our total
synthesis of (+)-lepadin F.
(16) (a) Wei, L.-L.; Sklenicka, H. M.; Gerasyuto, A. I.; Hsung, R. P.
Angew. Chem., Int. Ed. 2001, 40, 1516. (b) Sklenicka, H. M.; Hsung, R. P.;
McLaughlin, M. J.; Wei, L.-L.; Gerasyuto, A. I.; Brennessel, W. W. J. Am.
Chem. Soc. 2002, 124, 10435. (c) McLaughlin, M. J.; Hsung, R. P.; Cole,
K. C.; Hahn, J. M.; Wang, J. Org. Lett. 2002, 4, 2017. (d) Luo, S.; Zificsak,
C. Z.; Hsung, R. P. Org. Lett. 2003, 5, 4709. (e) Sydorenko, N.; Zificsak,
C. A.; Gerasyuto, A. I.; Hsung, R. P. Org. Biomol. Chem. 2005, 3, 2140.
(f) Swidorski, J. J.; Wang, J.; Hsung, R. P. Org. Lett. 2006, 8, 777. (g)
Wang, J.; Swidorski, J. J.; Sydorenko, N.; Hsung, R. P.; Coverdale, H. A.;
Kuyava, J. M.; Liu, J. Heterocycles 2006, 70, 423. (h) Gerasyuto, A. I.;
Hsung, R. P. Org. Lett. 2006, 8, 4899. (i) Gerasyuto, A. I.; Hsung, R. P. J.
Org. Chem. 2007, 72, 2476.
(12) Slafer, B.; Hsung, R. P.; Sklenicka, H. M. Abstracts of Papers,
227th National Meeting of the American Chemical Society, Anaheim, CA,
Spring 2004; American Chemical Society: Washington, DC, 2006; ORGN-
396.
(17) Both antipodes of lepadin F have been reported independently with
Wright et al. [reference 3] documenting (-)-F while Carroll et al. [reference
4] reporting (+)-F. Although no commitment was made regarding its
absolute configuration, in Wright’s paper, (-)-leapdin F was drawn as the
enantiomer of the one shown in Figure 1, and we elected to show Carroll’s
drawing of (+)-F.
(13) For reviews, see: (a) Harrity, J. P. A.; Provoost, O. Org. Biomol.
Chem. 2005, 3, 1349. (b) Hsung, R. P.; Kurdyumov, A. V.; Sydorenko, N.
Eur. J. Org. Chem. 2005, 23. (c) Coverdale, H. A.; Hsung, R. P. ChemTracts
2003, 16, 238
.
4992
Org. Lett., Vol. 10, No. 21, 2008